Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 81.20. Sh  (1)
  • Hypoxanthine-guanine phosphoribosyltransferase  (1)
  • Ribosephosphate pyrophosphokinase  (1)
  • 1
    ISSN: 1432-0649
    Keywords: 42.40 ; 81.20. Sh
    Source: Springer Online Journal Archives 1860-2000
    Topics: Physics
    Notes: Abstract New holographic recording materials based on photopolymerizable systems have contributed significantly to the recent growth of holographic applications. Previously, we reported that in photopolymerizable systems with a difunctional monomer, Ethylene Glycol DiMethAcrylate (EGDMA) improves the behaviour of the system and explains the role played by an eosin ester that has an oxo-oxime group in the production of amine initiator radicals. This comparative study was carried out in our laboratory using differential scanning photo-calorimetry and holography. The results of the new photosensitive recording materials for holography indicate that this system can be used for the formulation of very promising photopolymers that have a better performance. The aim of this study was to change the crosslinking monomer in order to increase the energetic sensitivity and discover the rest of the behavior. The new photo-polymerizable mixture contains PentaErythritol TriAcrylate (PETA) in a 1:1 ratio of volume and a 2-Hydroxy-Ethylene MethAcrylate monomer (HEMA). A diffraction efficiency of 80% is achieved with an energetic sensitivity of 3 J/cm2 at 514 nm, and the spatial resolution is up to 2000 lines/mm.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Pharmacy world & science 16 (1994), S. 40-54 
    ISSN: 1573-739X
    Keywords: Adenosine deaminase ; Adenosine triphosphate ; Hypoxanthine-guanine phosphoribosyltransferase ; Purine-pyrimidine metabolism, inborn errors ; Ribosephosphate pyrophosphokinase ; Uric acid
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology
    Notes: Abstract Purine nucleotides are synthesized and degraded through a regulated series of reactions which end in the formation of uric acid. Increased uric acid synthesis may be the result of two major pathophysiological disorders: increasedde novo purine synthesis and enhanced purine nucleotide degradation, both of which may be the result of an increased or decreased enzyme activity. In addition, some conditions and disorders associated with uric acid overproduction have been recognized as the result of increased ATP degradation or decreased synthesis of ATP. The clinical manifestations of the diseases leading to excess uric acid synthesis are heterogenous, but symptoms related to uric acid overproduction are always secondary to the precipitation of crystals in soft tissues, joints, and the kidney excretory system. In clinical practice, serum urate concentration and urinary uric acid excretion arc used to assess uric acid synthesis, taking into account that a purine-rich diet can be a confounding variable. Quantification of uric acid precursors, such as adenosine, inosine, guanosine, hypoxanthine, and xanthine, in biological fluids and intracellular nucleotides has provided further insight into the metabolic disturbances underlying disorders associated with uric acid overproduction. Additional studies are necessary to define precisely the metabolic derangement in idiopathic uric acid overproduction and to assess fully the consequences of increased purine nucleotide degradation, such as free-radical formation, increased adenosine synthesis, and reduced synthesis of signal transducers.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...